UPDATE : Monday, September 7, 2020
상단여백
EU approvals for Samsung Bioepis push up share prices
Investors are showing higher expectation for Samsung Bioepis, a Samsung Gro...
by Nam Doo-hyun  |  2017-09-18 14:45
라인
‘Knowledge’ is core ability for bio industrialists, survey says
“Knowledge” is the most important element for people engaged in bio and hea...
by Nam Doo-hyun  |  2017-09-15 16:28
라인
Experts call for overhauling bio industry promotion policy
Before the announcement of the “third draft to enhance biotechnology,” expe...
by Nam Doo-hyun  |  2017-09-15 15:39
라인
New VC investments in bio, medical fields fall sharpest in H1
New venture capital investments in bio and medical industries have fallen m...
by Nam Doo-hyun  |  2017-09-13 13:23
라인
China, Australia emerge as promising markets for medical equipment makers
Australia has emerged as the promising market for Korean medical equipment ...
by Nam Doo-hyun  |  2017-09-12 17:40
라인
Brokerage analyzes profit-sharing structure of Celltrion group
Local stock analysts’ eyes are now on the profit-sharing structure of the C...
by Nam Doo-hyun  |  2017-09-12 16:55
라인
Drugmakers adopt VR in sales, promotion
Korean drugmakers have set out to use virtual reality programs to promote a...
by Nam Doo-hyun  |  2017-09-11 17:21
라인
Experts stress need for drug treatments to control cholesterol
Korean Society of Lipid & Atherosclerosis (KSoLA) has come out to emphasize...
by Nam Doo-hyun  |  2017-09-11 12:01
라인
Investment into GMP facility needed to export bio medicines
It is urgent for the government to invest in the construction of Good Manuf...
by Nam Doo-hyun  |  2017-09-11 11:59
라인
Drugmakers introduce VR for diabetes therapy
Chong Kun Dang Pharmaceutical종근당(CEO: Kim Young-joo 김영주) and MSD Korea 한국MS...
by Nam Doo-hyun  |  2017-09-06 17:12
라인
Papers related to stem cell therapy rising worldwide
Seoul National University서울대학교, Catholic University of Korea가톨릭대학교, and Sch...
by Nam Doo-hyun  |  2017-09-06 16:45
라인
‘Mooncare’ helps bio, pharmaceutical stocks overcome NK risks
Amid escalating North Korea risks caused by the North’s nuclear and missile...
by Nam Doo-hyun  |  2017-09-05 16:45
라인
Survey tracks reasons Chinese come to Korea for cosmetic surgery
What makes Chinese tourists come to Korea for cosmetic surgery to account f...
by Nam Doo-hyun  |  2017-09-04 14:20
라인
‘AI to boost success rates, effectiveness for clinical trials’
Artificial intelligence such as rote learning is expected to boost success ...
by Nam Doo-hyun  |  2017-08-28 14:34
라인
Ferring’s offshoot swindled by email mimicking headquarter office
Ferring Pharmaceuticals has recently been conned out of tens of millions of...
by Nam Doo-hyun  |  2017-08-25 17:54
라인
Pharmaceutical sectors of major countries show mixed results
Korea, U.S., and Japanese pharmaceutical industries recorded trade deficits...
by Nam Doo-hyun  |  2017-08-24 18:35
라인
Quadrivalent influenza vaccines enter fierce sales competition
The competition among quadrivalent products is increasingly intensifying in...
by Nam Doo-hyun  |  2017-08-24 15:04
라인
Bio firms blame small R&D spending for low technology
Korea’s bio businesses cite “lack of R&D investment” as the main reason for...
by Nam Doo-hyun  |  2017-08-24 11:31
라인
Triumeq aims to change HIV drug market with easy use
GSK has released Triumeq Tab. to treat human immunodeficiency virus(HIV), d...
by Nam Doo-hyun  |  2017-08-23 12:12
라인
Celltrion’s move to main stock market draws investor concern
The recent decision by Celltrion, Korea’s most successful biosimilar maker,...
by Nam Doo-hyun  |  2017-08-22 17:01
여백
여백
여백
Back to Top